Innovazione nel mieloma multiplo: perché informazione e supporto restano cruciali

Therapeutic innovation in multiple myeloma opens up unprecedented possibilities, but also raises new questions about patient journeys. How can we support those living with the disease for a long time? What role do information, psychological support, and proximity to services play in the face of increasingly complex treatments? And how can we combine scientific advances with truly person-centered care? Amidst both opportunities and challenges, the need to rethink care in a more integrated way emerges. We discussed this with Davide Petruzzelli, whom we met at the event dedicated to new CAR-T therapies in multiple myeloma.